Your session is about to expire
← Back to Search
Study Summary
This trial is testing a new treatment for small choroidal melanoma. The treatment is an injection into the suprachoroidal space and the primary objective is to assess the safety and efficacy of this new treatment.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My scans show no signs of cancer spread.I have an active eye condition.I have not received any treatments for my condition.I have been diagnosed with a small eye melanoma or an uncertain eye lesion.
- Group 1: Cohort 1 AU-011 & Laser
- Group 2: Cohort 2 AU-011 & Laser
- Group 3: Cohort 3 AU-011 & Laser
- Group 4: Cohort 4 AU-011 & Laser
- Group 5: Cohort 5 AU-011 & Laser
- Group 6: Cohort 6 AU-011 & Laser
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the likelihood of serious side effects from AU-011?
"AU-011's efficacy has not yet been clinically proven, however, there is some data supporting safety, warranting a score of 2."
Are there different sites where this research is being conducted?
"For this study, there are a total of 21 enrolling patients from locations such as UCHealth Eye Center in Aurora, Retina Center in Minneapolis, and University of Illinois At Chicago Illinois Eye and Ear Infirmary in Chicago."
How many research subjects are being accepted into this trial?
"The sponsor, Aura Biosciences, needs to recruit 58 patients that meet the inclusion criteria from multiple sites in order to proceed with the study. Some of these locations include UCHealth Eye Center in Aurora, Colorado and Retina Center in Minneapolis, Minnesota."
Share this study with friends
Copy Link
Messenger